Calcineurin-independent regulation of plasma membrane Ca2+ ATPase-4 in the vascular smooth muscle cell cycle

Am J Physiol Cell Physiol. 2003 Jul;285(1):C88-95. doi: 10.1152/ajpcell.00518.2002. Epub 2003 Mar 26.

Abstract

Calcineurin mediates repression of plasma membrane Ca2+-ATPase-4 (PMCA4) expression in neurons, whereas c-Myb is known to repress PMCA1 expression in vascular smooth muscle cells (VSMC). Here, we describe a novel mouse VSMC line (MOVAS) in which 45Ca efflux rates decreased 50%, fura 2-AM-based intracellular Ca2+ concentrations ([Ca2+]i) increased twofold, and real-time RT-PCR and Western blot revealed a approximately 40% decrease in PMCA4 expression levels from G0 to G1/S in the cell cycle, where PMCA4 constituted approximately 20% of total PMCA protein. Although calcineurin activity increased fivefold as MOVAS progressed from G0 to G1/S, inhibition of this increase with either BAPTA or retroviral transduction with peptide inhibitors of calcineurin (CAIN), or its downstream target nuclear factor of activated T cells (NFAT) (VIVIT), had no effect on the repression of PMCA4 mRNA expression at G1/S. By contrast, Ca2+-independent activity of the calmodulin-dependent protein kinase-II (CaMK-II) increased eightfold as MOVAS progressed from G0 to G1/S, and treatment with an inhibitor of CaMK-II (KN-93) or transduction of a c-Myb-neutralizing antibody significantly alleviated the G1/S-associated repression of PMCA4. These data show that G1/S-specific PMCA4 repression in proliferating VSMC is brought about by c-Myb and CaMK-II and that calcineurin may regulate cell cycle-associated [Ca2+]i through alternate targets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / pharmacology
  • Benzylamines / pharmacology
  • Calcineurin / metabolism*
  • Calcineurin Inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism
  • Calcium-Transporting ATPases / genetics
  • Calcium-Transporting ATPases / metabolism*
  • Carrier Proteins / genetics
  • Cation Transport Proteins
  • Cell Line
  • Cell Membrane / enzymology
  • Cell Size / physiology
  • Chelating Agents / pharmacology
  • Egtazic Acid / analogs & derivatives*
  • Egtazic Acid / pharmacology
  • Enzyme Inhibitors / pharmacology
  • G1 Phase / physiology
  • Gene Expression Regulation, Enzymologic / physiology
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Smooth, Vascular / cytology*
  • Muscle, Smooth, Vascular / enzymology*
  • Oligopeptides / genetics
  • Phenotype
  • Plasma Membrane Calcium-Transporting ATPases
  • Proto-Oncogene Proteins c-myb / immunology
  • Proto-Oncogene Proteins c-myb / metabolism
  • S Phase / physiology
  • Sulfonamides / pharmacology
  • Transfection

Substances

  • Antibodies
  • Benzylamines
  • Calcineurin Inhibitors
  • Carrier Proteins
  • Cation Transport Proteins
  • Chelating Agents
  • Enzyme Inhibitors
  • Oligopeptides
  • Proto-Oncogene Proteins c-myb
  • Sulfonamides
  • VIVIT peptide
  • KN 93
  • Egtazic Acid
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Calcineurin
  • Plasma Membrane Calcium-Transporting ATPases
  • Atp2b1 protein, mouse
  • Calcium-Transporting ATPases
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid